Windsor Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-5,127
| Closed | -$323K | – | 119 |
|
|
2021
Q1 | $323K | Sell |
5,127
-2,108
| -29% | -$131K | 0.11% | 92 |
|
|
2020
Q4 | $448K | Sell |
7,235
-300
| -4% | -$18.4K | 0.17% | 85 |
|
|
2020
Q3 | $454K | Hold |
7,535
| – | – | 0.19% | 83 |
|
|
2020
Q2 | $443K | Hold |
7,535
| – | – | 0.19% | 84 |
|
|
2020
Q1 | $420K | Sell |
7,535
-410
| -5% | -$25.1K | 0.21% | 80 |
|
|
2019
Q4 | $509K | Hold |
7,945
| – | – | 0.21% | 81 |
|
|
2019
Q3 | $402K | Buy |
7,945
+2,883
| +57% | +$135K | 0.18% | 93 |
|
|
2019
Q2 | $229K | Sell |
5,062
-10,649
| -68% | -$496K | 0.11% | 107 |
|
|
2019
Q1 | $749K | Buy |
15,711
+410
| +3% | +$20.4K | 0.35% | 65 |
|
|
2018
Q4 | $795K | Sell |
15,301
-766
| -5% | -$41.2K | 0.41% | 59 |
|
|
2018
Q3 | $997K | Sell |
16,067
-717
| -4% | -$42.5K | 0.45% | 56 |
|
|
2018
Q2 | $928K | Buy |
16,784
+1,267
| +8% | +$68.4K | 0.43% | 57 |
|
|
2018
Q1 | $981K | Sell |
15,517
-533
| -3% | -$34.3K | 0.46% | 53 |
|
|
2017
Q4 | $983K | Buy |
16,050
+1,196
| +8% | +$74.8K | 0.46% | 46 |
|
|
2017
Q3 | $827K | Hold |
14,854
| – | – | 0.42% | 51 |
|
|
2017
Q2 | $827K | Sell |
14,854
-161
| -1% | -$8.76K | 0.42% | 51 |
|
|
2017
Q1 | $816K | Buy |
15,015
+1,165
| +8% | +$63.9K | 0.42% | 52 |
|
|
2016
Q4 | $809K | Buy |
13,850
+469
| +4% | +$25.6K | 0.44% | 47 |
|
|
2016
Q3 | $721K | Buy |
13,381
+1,255
| +10% | +$80.6K | 0.39% | 49 |
|
|
2016
Q2 | $891K | Buy |
12,126
+506
| +4% | +$35.8K | 0.52% | 43 |
|
|
2016
Q1 | $742K | Buy |
11,620
+6,802
| +141% | +$429K | 0.46% | 53 |
|
|
2015
Q4 | $331K | Hold |
4,818
| – | – | 0.21% | 86 |
|
|
2015
Q3 | $285K | Hold |
4,818
| – | – | 0.17% | 91 |
|
|
2015
Q2 | $320K | Sell |
4,818
-182
| -4% | -$12K | 0.19% | 87 |
|
|
2015
Q1 | $323K | Hold |
5,000
| – | – | 0.19% | 87 |
|
|
2014
Q4 | $295K | Hold |
5,000
| – | – | 0.17% | 83 |
|
|
2014
Q3 | $256K | Sell |
5,000
-1,360
| -21% | -$67.9K | 0.15% | 86 |
|
|
2014
Q2 | $309K | Hold |
6,360
| – | – | 0.17% | 74 |
|
|
2014
Q1 | $330K | Buy |
6,360
+1,360
| +27% | +$72.4K | 0.2% | 66 |
|
|
2013
Q4 | $266K | Sell |
5,000
-67
| -1% | -$3.41K | 0.16% | 73 |
|
|
2013
Q3 | $235K | Hold |
5,067
| – | – | 0.14% | 75 |
|
|
2013
Q2 | $226K | Buy |
+5,067
| New | +$220K | 0.14% | 73 |
|
Other funds holding BMY
Windsor Capital Management's BMY Position: Q2 2021 in Review
Windsor Capital Management sold out of Bristol-Myers Squibb (BMY) in Q2 2021, closing a stake of 5,127 shares — an estimated $323K sold.
Windsor Capital Management first reported a position in BMY in Q2 2013 and held it in 32 quarters. The position peaked at $997K in Q3 2018. 2,370 funds tracked by Wall St. Rank hold BMY as of Q2 2021.
- Windsor Capital Management reported no remaining Bristol-Myers Squibb position as of Q2 2021 after selling out during the quarter.
- Windsor Capital Management sold 5,127 Bristol-Myers Squibb shares in Q2 2021, an estimated $323K.
- Windsor Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 32 quarters.
- Windsor Capital Management's Bristol-Myers Squibb position peaked at $997K in Q3 2018.
- 2,370 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2021.
Based on Windsor Capital Management's 13F filing for Q2 2021, filed 12 Aug 2021.